concentrated tirzepatide + B6 (Pyridoxine) | 10mL Multi-Dose Weight Loss Injection Compounded Tirzepatide Weight Loss Program

Int J Pept Res Ther2026 Mar 10;32(2):38

In the STEP clinical trial program, weekly subcutaneous semaglutide 2.4 mg produced mean weight loss of 14.9% at 68 weeks in the STEP 1 trial

However, if side effects persist or worsen over time, it is important to consult with a healthcare provider

Specifically, GHK-Cu activates TGF-beta/SMAD-mediated collagen synthesis and extracellular matrix remodeling through copper-dependent enzyme pathways

GLP-1 receptor agonists, including medications like semaglutide, are a group of therapeutics that function by mimicking a naturally occurring hormone to regulate glucose levels and appetite

Vitamin considerations: Discuss appropriate multivitamin support with your healthcare provider